Veradermics Shares Surge 150% Post-IPO; CEO to Appear on NYSE Live
Veradermics shares have jumped 150% since pricing its IPO last week, marking one of the most robust debut performances on the NYSE. CEO Dr. Reid Waldman will discuss the surge and company outlook during a segment on NYSE Live today.
1. Post-IPO Share Performance
Veradermics launched its IPO last week and has seen its shares rise over 150% since pricing, reflecting strong investor demand and a standout market debut on the NYSE.
2. CEO to Join NYSE Live
Dr. Reid Waldman, CEO of Veradermics, will appear on NYSE Live today to discuss the share surge, articulate key drivers behind the performance and provide insights into the company’s strategic outlook following its IPO.
Related News
GOOG
OpenAI Eyes Fall IPO After Lawsuit Win, Battling $900B Anthropic Rival
GOOG•
ZKH
ZKH Group 1Q GMV Rises 12.9% to RMB2.45B; Non-GAAP EBITDA Positive
ZKH•
ODV
Osisko Development Raises US$275M via 4.125% Convertible Notes with 25% Premium
ODV•
NVDA
Nvidia Q1 Net Income Surges 211% to $58.3B, Data Center Revenue Up 92%
NVDA•
SATS
SpaceX Sets $1.75 Trillion Valuation, Values EchoStar Shares at $42.40 in IPO Filing
SATS•
Sources
F